Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7451–7500 of 18652
the employment of Kurt Adzema, Executive Vice President and Chief Financial Officer, will terminate effective January 5, 2024.
Sanmina Corporation (the “Company”) announced the appointment of Jonathan Faust as Executive Vice President and Chief Financial Officer of the Company, effective December 18, 2023.
Allison E. Marino, Senior Vice President and Chief Accounting Officer of the Company, to Executive Vice President, Chief Financial Officer and Chief Accounting Officer of the Company, effective, in each case, January 1, 2024.
Mr. Trimble will retire from his positions as Chief Executive Officer and President of the Company and as a member of the Company’s board of directors (the “Board”) effective December 31, 2023 (the “Effective Date”).
the Board appointed Darrell W. Crate, Chairman of the Board, to serve as Chief Executive Officer of the Company, effective January 1, 2024.
On December 4, 2023, the Company announced the appointment of Michael W. Kalb as the Company's Executive Vice President and CFO, effective January 1, 2024.
On December 1, 2023, Alicia Grande, the Chief Financial Officer ("CFO") of Catalyst Pharmaceuticals, Inc. (the " Company ") informed the Company of her intent to retire as the Company's CFO at the end of 2023.
On December 6, 2023, Virpax Pharmaceuticals, Inc. (the “Company”) entered into an employment agreement with Gerald Bruce (the “Bruce Employment Agreement”).
The Confirmed Plan provides that on the Effective Date, all directors, managers, members, officers and employees of the Company will be deemed to have resigned without any further action. Each of the Company’s directors, William J. Clough, James F. O’Neil III, C. Stephen Cochennet, Corey A. Lambrecht, Sarah Tucker, Paul T. Addison, Jerry Sue Thornton and La Forrest V. Williams, and the Company’s remaining officers, including William J. Clough, General Counsel, James F. O’Neil III, Chief Executive Officer and Nick Grindstaff, Chief Financial Officer, ceased to be directors and officers of the Company, as applicable, on the Effective Date.
The Confirmed Plan provides that on the Effective Date, all directors, managers, members, officers and employees of the Company will be deemed to have resigned without any further action. Each of the Company’s directors, William J. Clough, James F. O’Neil III, C. Stephen Cochennet, Corey A. Lambrecht, Sarah Tucker, Paul T. Addison, Jerry Sue Thornton and La Forrest V. Williams, and the Company’s remaining officers, including William J. Clough, General Counsel, James F. O’Neil III, Chief Executive Officer and Nick Grindstaff, Chief Financial Officer, ceased to be directors and officers of the Company, as applicable, on the Effective Date.
McDavid Stilwell notified the Company on December 7, 2023 of his resignation as Chief Financial Officer, Principal Financial Officer and employee of the Company in order to pursue other opportunities, in each case to be effective on December 31, 2023.
Paula Dempsey was appointed as the Executive Vice President and Chief Financial Officer of the Company, effective as of December 4, 2023
On December 6, 2023, Richard Brand, the Principal Executive Officer and Chief Financial Officer of Fortune Rise Acquisition Corporation, a Delaware corporation (the “ Company ”), notified the Company of his plans to resign from the Company to pursue other opportunities, effective at the close of business on December 31, 2023.
appointed Teri Loxam as chief financial officer, principal financial officer and principal accounting officer, effective as of the later of March 1, 2024 or the filing of the Company’s annual report for the period ending December 31, 2023 (the “Effective Date”).
On December 4, 2023, D. Ashley Lee, the Executive Vice President, Chief Financial Officer and Treasurer of Artivion, Inc. (the “Company”), notified the Company of his decision to retire effective December 31, 2023 (the “Retirement Date”).
On December 4, 2023, the Company’s Board of Directors appointed Lance A. Berry as the Company’s Chief Financial Officer and Treasurer, effective as of that date.
Effective upon Mr. Naor’s appointment, Peter Mariani stepped down from his role as the Executive Vice President and Chief Financial Officer of the Company and Axogen Corporation, a Delaware corporation (“AC”) and wholly owned subsidiary of the Company, at the request of the Board.
On December 6, 2023, Axogen, Inc. (the “Company”) announced the appointment of Nir Naor as Chief Financial Officer, effective December 4, 2023.
Effective December 1 st , 2023, Odyssey Semiconductor Technologies, Inc. (the “Company”) Dr. Rick Brown, co-founder, CTO, and Board member, has been appointed as CEO of Odyssey, replacing Mark Davidson.
Mark Davidson is stepping down as CEO and Board Member and is no longer employed at Odyssey.
At the same date, Wei Zurui consented to act as the new Chief Financial Officer and Director of the Company.
Accordingly, Zhang Wenmin serving as Chief Financial Officer, ceased to be the Company’s Chief Financial Officer.
On December 4, 2023, the Board of Directors of the Company (the “Board”) approved the appointment of David Reeder as the Company’s CFO and principal financial officer, effective as of the date of Mr. Reeder’s employment with the Company, which is expected to be on February 14, 2024
which will coincide with the date that Mr. Charlesworth succeeds as the Company’s Chief Executive Officer.
On December 5, 2023, the Company announced the appointment of Craig D. Aaron, currently the Company’s Vice President and Controller, to the role of Executive Vice President and Chief Financial Officer, effective March 1, 2024, succeeding Mr. Nowlan in that role.
On November 30, 2023, Kevin A. Nowlan, Executive Vice President and Chief Financial Officer of BorgWarner Inc. (the “Company”), notified the Company of his intention to retire as Executive Vice President and Chief Financial Officer effective March 1, 2024.
In connection with Mr. Culleton’s appointment to serve as the Company’s Chief Executive Officer, on December 3, 2023, Dr. Culleton and ProKidney, LLC, a Delaware limited company and subsidiary of the Company, entered into an employment agreement, effective as of November 15, 2023 (the “Employment Agreement”), pursuant to which Dr. Culleton will serve as Chief Executive Officer of the Company and its subsidiaries and affiliates.
Mr. Roberts’ resignation from his positions as Chief Executive Officer, Chief Strategy Officer, and President of the Company on November 2, 2023
On December 4, 2023, Michael Messinger, Chief Executive Officer, President and Chief Financial Officer, and Natalie Bogdanos, General Counsel, Corporate Secretary & Data Protection Officer, tendered their resignations, effective on such date.
James (“Jim”) B. Gattoni will resign from his position as President and Chief Executive Officer and a member of the Company’s board of directors, effective February 2, 2024, to retire after a 28 year career with Landstar.
Frank A. Lonegro would join the Company as President and Chief Executive Officer and a member of the Company’s board of directors, effective February 2, 2024.
Brian Evans, who has been with the Company for 23 years and has served as the Company’s Chief Financial Officer for 14 years, was appointed Chief Executive Officer on November 29, 2023, effective January 1, 2024.
In the interim, the Company’s Vice President of Finance, Sarah Wyant, will be named Interim Chief Financial Officer and will assume the duties as the principal financial officer and principal accounting officer for the Company.
On December 4, 2023 Nxu, Inc. (the “Company”) received a notice of resignation from its Chief Financial Officer, Apoorv Dwivedi, effective January 12, 2024.
On November 30, 2023, Tom Jewell, the Senior Vice President, and Chief Financial Officer of Usio, Inc., (the “Company”) notified the Company of his intention to retire in order to spend time with his family and grandchildren, effective immediately.
Mr. LaFrence assumed the duties of chief financial officer and principal accounting officer from Alan Nordstrom.
On December 1, 2023, the Company entered into an Employment Agreement with Andrew D. C. LaFrence (the “LaFrence Agreement”) as the Company’s Chief Financial Officer and Senior Vice President of Finance effective December 1, 2023.
On November 21, 2023, Gina Serkasevich resigned from the positions of Chief Executive Officer (CEO) and Chief Financial Officer (CFO) of Hero Technologies Inc. (the “Company”) effective as of November 21, 2023.
Effective November 22, 2023, Destiny Aigbe, was appointed as Chief Executive Officer and sole director in Board of Directors (the “Board”) of Hero Technologies Inc. (the “Company”).
Mr. Bedingfield succeeds Michelle L. Turner.
On December 4, 2023, L3Harris Technologies, Inc. (“ L3Harris” or the “Company ”) announced that Kenneth L. Bedingfield has been named Senior Vice President and Chief Financial Officer of L3Harris, effective December 11, 2023.
Tam B. Nguyen has been appointed Senior Vice President, Chief Financial Officer, and Corporate Secretary of the Corporation and the Bank, effective January 2, 2024 succeeding Donavon P. Ternes who will become President and Chief Executive Officer on the same date.
Donavon P. Ternes who will become President and Chief Executive Officer on the same date.
Noémie C. Heuland will cease serving as Executive Vice President, Chief Financial Officer of the Company after December 31, 2023.
appointed Jeremy R. Johnson, age 40, to serve as principal financial officer of the Company through his appointment as Executive Vice President, Chief Financial Officer of the Company, effective January 1, 2024
Mr. Colquhoun will be taking over the CEO position from founder Jirka Rysavy.
On December 4, 2023, the Board of Directors (the “Board”) of Gaia, Inc. (the “Company” or “Gaia”) appointed James Colquhoun, age 42, as Chief Executive Officer, effective today.
On November 28, 2023, Lesaka Technologies, Inc. (the "Company") Group Chief Executive Officer, Mr. Chris Meyer, informed the Company's Board of Directors ("Board) of his intention to resign from his position as Group Chief Executive Officer of the Company effective as of February 29, 2024.
the Company terminated the employment of Timothy P. Clackson, Ph.D. as President and Chief Executive Officer of the Company, effective as of December 7, 2023
On November 29, 2023, the Board of Directors of Chimerix, Inc. (the “Company”) promoted Michelle LaSpaluto to the position of Chief Financial Officer of the Company, effective December 1, 2023.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.